Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (2,522,694)	$ (2,079,683)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	171,588	65,362
Stock-based compensation	260,311	110,593
Shares issued for professional services	190,500	400,600
Loss on impairment	162,984	0
Changes in assets and liabilities:
Accounts receivable	(65,740)	163
Inventories	(71,685)	12,836
Prepaid expenses and other assets	(43,793)	(76,986)
Accounts payable	(140,395)	(228,327)
Accrued expenses	(5,425)	(17,513)
Accrued interest	0	28,744
Contract liability	259,580	(1,927)
Payroll liabilities	(13,521)	8,000
Net cash used in operating activities	(1,818,290)	(1,778,138)
CASH FLOW FROM INVESTING ACTIVITIES:
Purchases of fixed assets	(24,445)	0
Cash received in reverse merger	0	256,255
Payments of liabilities assumed in reverse merger	0	(891,474)
Acquisition of Agribotix	0	(925,000)
Net cash used in investing activities	(24,445)	(1,560,219)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments of the principle on promissory note	(40,998)	(84,559)
Shares repurchased from shareholder	0	(210,643)
Proceeds from the issuance of Common Stock and Series C convertible preferred stock in connection with merger, net of $20,000 in fees	0	3,980,000
Proceeds from the sale of Series C convertible preferred stock	0	250,000
Proceeds from the issuance of Common Stock Series D	0	1,970,000
Net cash (used in) provided by financing activities	(40,998)	5,904,798
Net (decrease) increase in cash	(1,883,733)	2,566,441
Cash at beginning of period	2,601,730	35,289
Cash at end of period	717,997	2,601,730
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest cash paid	501	39,313
Income taxes paid	0	0
Accrued dividends	163,555	1,333
NONCASH INVESTING AND FINANCING ACTIVITIES:
Assets acquired and (liabilities assumed) in reverse merger cash	0	256,255
Assets acquired and (liabilities assumed) in reverse merger accounts payable	0	(891,474)
Promissory note	0	(125,556)
Net liabilities assumed	0	(760,775)
Conversion of debt into common stock	0	1,503,801
Conversion of Series B and C preferred stock into common stock	2,150	613
Issuance of common stock as consideration	0	3,000,000
Cash paid in the prior year	0	75,000
Deferred revenue	0	6,819
Inventory	0	(3,685)
Fixed assets	0	(7,650)
Intangible assets	0	(724,500)
Goodwill	0	(3,270,984)
Cash paid for acquisition	$ 0	$ (925,000)